Enveric Biosciences, Inc.
ENVBNasdaqCIK 890821HealthcareFiscal year ends Dec 31
Reports and events: 396 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-09-0418:43 ET | S-1 | Registration statement | 0001493152-24-035018 |
| 2024-08-2208:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-033501 |
| 2024-08-1217:13 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-031352 |
| 2024-08-1217:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-031340 |
| 2024-07-1508:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-027235 |
| 2024-05-2916:15 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-021787 |
| 2024-05-2308:00 ET | 8-K | 3.01 Delisting notice | 0001493152-24-021096 |
| 2024-05-1717:25 ET | 8-K | 3.01 Delisting notice | 0001493152-24-020489 |
| 2024-05-1521:20 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-019364 |
| 2024-05-1521:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-019362 |
| 2024-05-0317:04 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-24-017748 |
| 2024-04-1608:30 ET | DEF 14A | Proxy statementPeriod 2024-04-16 | 0001493152-24-014745 |
| 2024-03-2816:55 ET | 8-K | 5.08 Item not in the standard list | 0001493152-24-011774 |
| 2024-03-2608:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-011235 |
| 2024-03-2620:57 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001493152-24-011210 |
| 2024-03-1907:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-010419 |
| 2024-03-1108:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-24-009485 |
| 2024-02-2907:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-008264 |
| 2024-02-2108:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-007347 |
| 2024-02-0908:05 ET | 8-K | 3.01 Delisting notice | 0001493152-24-005561 |
| 2024-01-0816:42 ET | 8-K | 2.05 Exit or disposal costs | 0001493152-24-001717 |
| 2024-01-0308:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-000193 |
| 2023-12-2916:43 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001493152-23-046601 |
| 2023-12-2808:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-046327 |
| 2023-12-2708:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-046190 |
| 2023-12-0508:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-043656 |
| 2023-12-0116:31 ET | S-1/A | Registration statement, amended | 0001493152-23-043417 |
| 2023-11-2908:18 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-043004 |
| 2023-11-2216:30 ET | 8-K | 3.01 Delisting notice | 0001493152-23-042506 |
| 2023-11-1316:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-040499 |
| 2023-11-1316:06 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001493152-23-040493 |
| 2023-11-0818:06 ET | S-1 | Registration statement | 0001493152-23-039794 |
| 2023-11-0608:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-039443 |
| 2023-11-0217:29 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-23-039183 |
| 2023-10-3108:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-038791 |
| 2023-10-2008:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-037782 |
| 2023-10-1808:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-037564 |
| 2023-10-1108:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-036860 |
| 2023-10-0308:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-035137 |
| 2023-09-2708:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-033836 |
| 2023-09-2008:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-033137 |
| 2023-09-1816:50 ET | DEF 14A | Proxy statementPeriod 2023-09-18 | 0001493152-23-032930 |
| 2023-09-1808:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-032864 |
| 2023-09-1108:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-032196 |
| 2023-09-0508:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-031569 |
| 2023-09-0117:26 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-031526 |
| 2023-08-2817:13 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-030386 |
| 2023-08-2808:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-030301 |
| 2023-08-2107:55 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-029506 |
| 2023-08-1408:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-028048 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 3, 2026, 18:51 ET. Listed shows no prices and gives no investment advice.